Genome Biologics
Genome Biologics
  • Home
  • Therapies
  • Technology
  • Our team
  • Press
  • Horizon 2020
  • Contact us
    • Home
    • Therapies
    • Technology
    • Our team
    • Press
    • Horizon 2020
    • Contact us
  • Home
  • Therapies
  • Technology
  • Our team
  • Press
  • Horizon 2020
  • Contact us

Press Release

image228

Genome Biologics - AstraZeneca Research Collaboration

Genome Biologics enters into a research collaboration and exclusive license option agreement with AstraZeneca to identify drivers of cardiac regeneration and recovery in Myocardial Infarction, Heart Failure and Cardiotoxicity

Article

Press

image229

Top 100 Fastest Growing German Startup

Article
image230

Global Top 5 AI-Driven Drug Discovery Startup

Article
image231

Top 10 AI and Drug Discovery Company in Europe

Article
image232

Revolutionizing drug research with EU grants

Article

Awards

image233

Genome Biologics joins BLUE KNIGHT™

Blue Knight is a joint initiative between Johnson & Johnson Innovation–JLABS and the Biomedical Advanced Research and Development Authority (BARDA, of the U.S. Department of Health and Human Services),  that aims to stimulate and accelerate innovation to improve global health security. Genome Biologics is one of seven companies from across the globe selected to join Blue Knight.

Article
image234

Johnson & Johnson Innovations (JLABS) Resident

Genome Biologics is a resident company of Johnson & Johnson Innovation - JLABS, a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps entrepreneurs in pharmaceutical, medical device, consumer, and health tech bring healthcare solutions to patients and consumers.

Article
image235

European Innovation Council

SME Instrument Phase 1 & 2 winner

Article
image236

German Biotechnology Day

Johnson & Johnson Innovations challenge winner

Article
image237

Merck Innovations

Venture Lounge winner

Article

Copyright © 2020 Genome Biologics – Alle Rechte vorbehalten.

  • Privacy Policy